Speaking Engagement Preparing for Biosimilar Carve Outs: Will Skinny Labelling Work for Biosimilars? June 27, 2023 4:15 PM - 5:15 PM Boston, MA
Client Alert In Dupree, Supreme Court Unanimously Decides “Purely Legal” Issues Decided at Summary Judgment are Preserved for Appeal William H. Milliken Michael Joffre, Ph.D. May 25, 2023
Bylined Articles A Deep Dive Into EU Unified Patent Court Policy Law360 May 24, 2023 Robert Greene Sterne
In the News Reactions to Amgen: Hard Work Ahead for Biotech Innovators and Attorneys Trying to Enable Genus Claims IPWatchdog May 22, 2023
In the News In Amgen-Sanofi Decision, High Court Sticks to Patent Law Script Bloomberg Law May 19, 2023
Client Alert US Supreme Court Refocuses the Test for Transformative Use Ivy Clarice Estoesta William H. Milliken May 19, 2023
In the News Sanofi Can Thank Thomas Edison And Samuel Morse For IP Win The National Law Journal May 19, 2023
Client Alert Supreme Court Affirms Federal Circuit’s Decision in Amgen v. Sanofi William H. Milliken Michael Joffre, Ph.D. May 18, 2023
In the News Michel Puts Hope in ‘Imminent’ Patent Bills Following SCOTUS Eligibility Denials IPWatchdog May 16, 2023
Podcast Recording & Transcript A Chat with Ivy Clarice Estoesta, Director at Sterne Kessler May 15, 2023
Speaking Engagement Expanding Director and CEO Intellectual Property Responsibilities Under the E.U.'s New Unified Patent Court May 11, 2023 12:30 PM - 2:00 PM 3649 Cane Run Road, Louisville, Kentucky 40211
In the News Sterne Kessler Team Scores Federal Circuit Win for Teva in Sleep Disorder Drug Litigation Law360 May 10, 2023
In the News Sterne Kessler Represents Teva in Sleep Disorder Drug Win at Federal Circuit Bloomberg Law May 10, 2023